AI assistant
Sending…
BioAtla, Inc. — Director's Dealing 2024
Jan 4, 2024
34681_dirs_2024-01-03_83afeb2a-6b44-4bdf-a9f2-e8a30a2e4d53.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2023-12-31
Reporting Person: GRAY MARY ANN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | Common Stock | A | 5995 | $0.00 | Acquired | 37397 | Direct |
Footnotes
F1: The reporting person has elected to receive fully vested shares of the Issuer's common stock in lieu of cash retainer fees payable for service on the Issuer's Board of Directors and any committees thereof. The number of shares issued represents the quotient of (A) the amount of such fees divided by (B) the Issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share.
More from BioAtla, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 11
Regulatory Filings
2026
Feb 9
Regulatory Filings
2026
Feb 6